# Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

> **NCT00233402** · PHASE3 · COMPLETED · sponsor: **Photocure** · enrollment: 789 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Hexvix
- **PROCEDURE:** Standard white light cystoscopy

## Key facts

- **NCT ID:** NCT00233402
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 789 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233402, "Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00233402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*